The antiphospholipid syndrome is a prothrombotic disorder associated with autoantibodies.
It is associated with obstetrical complications (mainly spontaneous abortion) as well as …

Oxidative stress is increased in systemic lupus erythematosus (SLE), and it contributes to
immune system dysregulation, abnormal activation and processing of cell-death signals …

Recurrent thrombosis and miscarriages are the main clinical manifestations of
antiphospholipid syndrome (APS). Although most patients display both clinical signs, some …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies that have clear
associations with thrombosis and pregnancy morbidity, and which together constitute the …

Transaldolase deficiency predisposes to chronic liver disease progressing from cirrhosis to
hepatocellular carcinoma (HCC). Transition from cirrhosis to hepatocarcinogenesis depends …

Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory …

Antiphospholipid syndrome (APS) is an autoimmune antibody-mediated condition
characterized by thrombotic events and/or pregnancy morbidity in association with persistent …

The antiphospholipid syndrome (APS) is defined by the persistent presence of
antiphospholipid antibodies in patients with a history of thrombosis and/or pregnancy …

Protein targets in autoimmune disease vary in location, originating within cells as in system
lupus erythematosus (SLE), or found on cell surfaces or in extracellular spaces. The term …

Objective Antiphospholipid antibodies (aPL) constitute a diagnostic criterion of systemic
lupus erythematosus (SLE), and aPL have been functionally linked to liver disease in …